However, when sold for "research" or "anti-aging" purposes outside of its approved indication, it falls into a regulatory gray area
The SURMOUNT-OSA phase 3 clinical trial examined the use of tirzepatide for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity
Beyond pancreatic effects, GLP-1 slows gastric emptying, which moderates postprandial glucose excursions, and acts on central nervous system receptors to promote satiety and reduce appetite
He notes that while weight itself is not a measure of professional value, the confidence people gain from feeling healthier often affects how they show up at work
The dose is then titrated upward by .25 mg every week until the individual researcher reaches their recommended maintenance level based on their BMI
[PubMed] [Google Scholar] 82.Ivanova A.D., Kuzmin V.S